{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:48:24Z","timestamp":1790819304877,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National key research and development program of China","doi-asserted-by":"crossref","award":["2017YFC0906900"],"award-info":[{"award-number":["2017YFC0906900"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"State Key Project for Liver Cancer of China","award":["2017ZX10203206"],"award-info":[{"award-number":["2017ZX10203206"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670516,81370066"],"award-info":[{"award-number":["81670516,81370066"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003999","name":"Creative Research Groups of China","doi-asserted-by":"publisher","award":["81521091"],"award-info":[{"award-number":["81521091"]}],"id":[{"id":"10.13039\/501100003999","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Precision Medicine Project of Second Military Medical University","award":["2017JZ30"],"award-info":[{"award-number":["2017JZ30"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","cancerletters.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.canlet.2018.02.017","type":"journal-article","created":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:12:47Z","timestamp":1518567167000},"page":"161-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy"],"prefix":"10.1016","volume":"421","author":[{"given":"Yun-kai","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-yi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-hua","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-fei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-han","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-xiong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2018.02.017_bib1","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers","volume":"341","author":"de Groen","year":"1999","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.canlet.2018.02.017_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hep.20537","article-title":"Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy","volume":"41","author":"Sirica","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2018.02.017_bib3","article-title":"Targeting cholangiocarcinoma","author":"Mertens","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2018.02.017_bib4","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1200\/JCO.2009.27.4787","article-title":"Genetics of biliary tract cancers and emerging targeted therapies","volume":"28","author":"Hezel","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.canlet.2018.02.017_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s002689900233","article-title":"Intrahepatic cholangiocarcinoma","volume":"21","author":"Chu","year":"1997","journal-title":"World J. Surg."},{"key":"10.1016\/j.canlet.2018.02.017_bib6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1097","article-title":"RAS oncogenes: the first 30 years","volume":"3","author":"Malumbres","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.canlet.2018.02.017_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00534-002-0729-3","article-title":"Anatomic and molecular pathology of intrahepatic cholangiocarcinoma","volume":"10","author":"Nakanuma","year":"2003","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.canlet.2018.02.017_bib8","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1038\/ncomms6696","article-title":"Mutational landscape of intrahepatic cholangiocarcinoma","volume":"5","author":"Zou","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2018.02.017_bib9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0304-3835(01)00562-6","article-title":"Genetic alterations in gallbladder adenoma, dysplasia and carcinoma","volume":"169","author":"Kim","year":"2001","journal-title":"Cancer Lett"},{"key":"10.1016\/j.canlet.2018.02.017_bib10","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.1074\/jbc.273.22.13375","article-title":"The tumor suppressor, PTEN\/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate","volume":"273","author":"Maehama","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.canlet.2018.02.017_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0955-0674(98)80149-X","article-title":"Mechanisms and consequences of activation of protein kinase B\/Akt","volume":"10","author":"Downward","year":"1998","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.canlet.2018.02.017_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(03)00309-X","article-title":"Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse","volume":"4","author":"Hingorani","year":"2003","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2018.02.017_bib13","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1101\/gad.1158703","article-title":"Activated Kras and Ink4a\/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma","volume":"17","author":"Aguirre","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2018.02.017_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2018.02.017_bib15","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1101\/gad.1478706","article-title":"Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer","volume":"20","author":"Bardeesy","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2018.02.017_bib16","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1101\/gad.1475506","article-title":"Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression","volume":"20","author":"Ijichi","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2018.02.017_bib17","doi-asserted-by":"crossref","first-page":"8248","DOI":"10.1073\/pnas.0912203107","article-title":"The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis","volume":"107","author":"Lee","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2018.02.017_bib18","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1158\/0008-5472.CAN-11-3596","article-title":"Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma","volume":"72","author":"O'Dell","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.canlet.2018.02.017_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ccell.2016.07.005","article-title":"A\u00a0critical role for notch signaling in the formation of cholangiocellular carcinomas","volume":"30","author":"Zender","year":"2016","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2018.02.017_bib20","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1172\/JCI27282","article-title":"Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice","volume":"116","author":"Xu","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.canlet.2018.02.017_bib21","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0092-8674(94)90041-8","article-title":"Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9","volume":"79","author":"Wagner","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2018.02.017_bib22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/ajg.2011.305","article-title":"Expression and clinicopathological significance of notch signaling and cell-fate genes in biliary tract cancer","volume":"107","author":"Mazur","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.canlet.2018.02.017_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.21037\/hbsn.2016.11.04","article-title":"Pathology of intrahepatic cholangiocarcinoma","volume":"6","author":"Vijgen","year":"2017","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.canlet.2018.02.017_bib24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0046-8177(03)00337-X","article-title":"Molecular and immunohistochemical analysis of intraductal papillary neoplasms of the biliary tract","volume":"34","author":"Abraham","year":"2003","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2018.02.017_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/path.4189","article-title":"PTEN loss and KRAS activation cooperate in murine biliary tract malignancies","volume":"230","author":"Marsh","year":"2013","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.canlet.2018.02.017_bib26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/1471-2407-10-631","article-title":"Targeting EGFR\/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas","volume":"10","author":"Pignochino","year":"2010","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2018.02.017_bib27","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/hep.22238","article-title":"Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin","volume":"47","author":"Komuta","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2018.02.017_bib28","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.canlet.2018.02.017_bib29","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1053\/j.gastro.2009.02.051","article-title":"Intrahepatic bile ducts develop according to a new mode of tubulogenesis regulated by the transcription factor SOX9","volume":"136","author":"Antoniou","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2018.02.017_bib30","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2018.02.017_bib31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/00000478-200105000-00003","article-title":"Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions","volume":"25","author":"Hruban","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2018.02.017_bib32","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1073\/pnas.0609217104","article-title":"SOX9 is required for maintenance of the pancreatic progenitor cell pool","volume":"104","author":"Seymour","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2018.02.017_bib33","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/nm.4437","article-title":"Enhancing the precision of genetic lineage tracing using dual recombinases","volume":"23","author":"He","year":"2017","journal-title":"Nat. Med."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518301502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383518301502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T00:51:09Z","timestamp":1589849469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383518301502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":33,"alternative-id":["S0304383518301502"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2018.02.017","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of Kras activation and PTEN deletion contributes to murine hepatopancreatic ductal malignancy","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2018.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}